What Are the Risk Factors for BPH Beyond Aging?

Aging and hormones are the two most firmly established risk factors for benign prostatic hyperplasia, but the list extends well beyond them. BPH, the noncancerous enlargement of the prostate that gradually narrows the urethra and causes urinary symptoms, involves a web of metabolic, inflammatory, genetic, and lifestyle influences that researchers have been untangling for decades. Some of these factors you can’t change; others you can.

Age Towers Over Everything Else

No risk factor for BPH comes close to age. The overgrowth of tissue in the prostate’s inner zones first becomes detectable around a man’s fourth decade of life and affects nearly all men by the ninth decade.¹ The process is slow enough that many men in their forties and fifties never notice it, but as the decades pass, the prostate keeps growing and the odds of bothersome symptoms climb steeply. A large Chinese study found that after age 61, every standard measure of BPH progression, from symptom scores to prostate volume to residual urine, was positively correlated with age, and the strength of that correlation kept rising with each passing year.²

Why age matters so much is partly hormonal, partly inflammatory, and partly just the accumulated effect of decades of cell turnover in a gland that, unlike most organs, never stops growing. The sections that follow cover each of those threads in turn.

Hormones and the Androgen-Estrogen Balance

The prostate depends on androgens to develop and maintain itself, so it’s no surprise that androgen signaling is central to BPH. Testosterone produced by the testes gets converted inside prostate cells into a more potent form called dihydrotestosterone (DHT), which binds to receptors and drives gene activity that promotes cell growth.³ This is why drugs that block the conversion of testosterone to DHT can shrink an enlarged prostate.

But androgens aren’t acting alone. Estrogen, present in men in small amounts, appears to amplify prostate growth when it works alongside testosterone. Animal research shows that giving testosterone alone causes glandular growth, but adding estrogen on top produces even greater enlargement along with bladder obstruction.⁴ The ratio between the two hormones matters: rat studies indicate that when the estrogen-to-testosterone ratio shifts past a certain balance point, the conditions for prostatic hyperplasia are set up.⁵ As men age, testosterone levels decline while estrogen levels remain relatively stable or even increase, pushing that ratio in a direction that favors prostate growth. This hormonal shift is one reason age and hormones are so tightly linked as risk factors.

Family History and Genetic Susceptibility

If your father or brother had an enlarged prostate, your risk goes up. A population-based study found that men with a family history of BPH were more likely to develop urinary symptoms themselves, and the risk was even higher, roughly two and a half times the baseline, when relatives had been diagnosed at a younger age.⁶ Research on familial clustering suggests the most likely inheritance pattern is autosomal dominant or codominant, meaning you don’t need to inherit a gene variant from both parents for it to have an effect.⁷

The genetic component is strongest for the most clear-cut cases: early onset, large prostate volume, and strong family history. For milder, symptom-based BPH, the genetic signal weakens. This means that if several men in your family needed treatment for an enlarged prostate before age 60, you have a particularly good reason to pay attention to the modifiable risk factors covered below.

Metabolic Syndrome, Obesity, and Insulin Resistance

Over the past two decades, metabolic health has emerged as one of the most important modifiable risk factors for BPH. The cluster of conditions known as metabolic syndrome, which includes excess abdominal fat, high blood sugar, elevated blood pressure, and unfavorable cholesterol levels, has been linked to larger prostates and faster prostate growth. One study found that men with metabolic syndrome had an average prostate volume of about 49 mL compared with roughly 29 mL in men without it, and the annual growth rate was nearly 50 percent higher.⁸

Insulin resistance appears to be the thread tying these metabolic problems to the prostate. When the body becomes less responsive to insulin, circulating insulin levels rise to compensate. That excess insulin can stimulate prostate cell growth directly and also shift other molecular signals, including growth factors and sex hormones, in ways that promote enlargement.⁹ Obesity, unfavorable lipid levels, and overactive sympathetic nerve signaling each individually increase the risk, and insulin resistance connects them all.¹⁰

The diabetes connection deserves a specific mention. Among elderly men newly diagnosed with type 2 diabetes, those with poorer blood-sugar control (higher hemoglobin A1c) had worse symptom scores, larger prostates, and weaker urine flow compared with men whose blood sugar was better managed.¹¹ Managing weight and keeping blood sugar in check may slow BPH progression for men in this group. Researchers have noted that shared molecular pathways between metabolic syndrome and BPH, including insulin-like growth factor 1 and various adipose-tissue hormones, raise the possibility that treating one condition could help alleviate the other.¹²

Chronic Inflammation

Inflammation inside the prostate itself is commonly found in surgical tissue samples, and growing evidence suggests it isn’t just a bystander. Various growth factors and signaling molecules that promote inflammation can also drive the overgrowth of prostate tissue, making chronic prostatic inflammation a plausible contributor to enlargement.¹³

Systemic inflammation, the kind detectable through a blood test, appears relevant too. C-reactive protein (CRP), a marker of body-wide inflammation, has been associated with faster worsening of urinary symptoms. In one community-based study, men with elevated CRP were about twice as likely to experience rapid increases in irritative urinary symptoms compared with men whose CRP was low.¹⁴ Data from the large Prostate Cancer Prevention Trial showed a similar trend: men in the highest quarter of CRP levels had about a 40 percent higher risk of developing BPH compared with the lowest quarter, though that association weakened after accounting for body mass index.¹⁵ Among men who already had BPH, those with the most severe symptoms also had significantly higher CRP levels.¹⁶

The overlap with metabolic syndrome is hard to miss: obesity drives CRP up, and adjusting for body mass index often weakens the CRP-BPH link. This suggests that some of the inflammation story is really a metabolic story in disguise, though the two likely reinforce each other.

Vascular Health and Atherosclerosis

Conditions that damage blood vessels, including hypertension, high cholesterol, and atherosclerosis, have been linked to BPH as well. The logic runs through the prostate’s blood supply. If the arteries feeding the prostate become stiffened and narrowed, the resulting chronic low-grade oxygen deprivation appears to set off stress responses that promote tissue growth.¹⁷ In human surgical specimens, atherosclerosis of the prostatic artery was significantly associated with larger prostate size, and the molecular evidence pointed to oxidative stress pathways as the connection.

The same cardiovascular risk factors that clog coronary arteries and cause erectile dysfunction may be contributing to prostate enlargement and urinary symptoms through reduced pelvic blood flow.¹⁸ This shared vascular mechanism helps explain why BPH, erectile dysfunction, and heart disease so often travel together in the same patients.

Physical Activity

Exercise is one of the clearest protective factors. A meta-analysis pooling multiple studies found that men who engaged in moderate or heavy physical activity had about 25 percent lower odds of BPH or urinary symptoms compared with sedentary men.¹⁹ The benefit appears to follow a dose-response pattern: a large epidemiological study found that men in the highest activity group had 25 percent lower odds of needing BPH surgery than the least active group.²⁰

A study of runners made the relationship especially vivid: men who ran longer distances had progressively lower BPH risk, and faster runners had lower risk than slower ones. Even among the fastest group, the next-fastest category still had significantly higher risk, suggesting the protection extends across a wide fitness spectrum rather than plateauing at a modest level of activity.²¹ The mechanisms likely involve improvements in insulin sensitivity, reduced inflammation, better cardiovascular function, and lower sympathetic nervous system activity, all of which tie back to other risk factors already discussed.

Alcohol and Smoking

The relationship between alcohol and BPH is counterintuitive. A pooled analysis of 19 studies covering more than 120,000 men found that moderate to heavy alcohol intake was associated with a significantly lower likelihood of BPH. Compared with nondrinkers, men consuming roughly 36 grams of alcohol per day or more had about 35 percent lower odds of BPH.²² Another study found that the protective association was strongest at moderate levels, around 30 to 50 grams per day, and somewhat attenuated at the highest intake levels.²³

This does not mean drinking is a recommended treatment strategy. The same pooled analysis noted that three of four studies using urinary symptoms as the outcome actually found increased symptoms with alcohol consumption.²⁴ In other words, alcohol may reduce the structural disease but worsen the day-to-day bother, possibly because alcohol is a diuretic that increases urine output and bladder irritability. The mechanisms behind the apparent protective effect on the gland itself are debated; one hypothesis involves alcohol’s dampening effect on sympathetic nervous system activity.

Smoking presents a mixed picture. One study found that current smokers actually had smaller prostates than nonsmokers, possibly related to smoking’s effects on hormone levels: smokers had significantly higher estradiol levels, which at first glance might seem like it would increase BPH, but the overall hormonal impact of smoking on prostate growth appears to be mildly suppressive.²⁵ However, heavy smoking has also been linked to chronic sympathetic nervous system overactivity, which is itself a driver of BPH symptoms.²⁶ The evidence is not clean enough to say smoking definitively protects or harms the prostate, and nobody in urology is suggesting cigarettes as a preventive measure.

The Sympathetic Nervous System

Your autonomic nervous system, the part that handles fight-or-flight responses, may play a larger role in BPH than most people realize. Research has found that autonomic overactivity is significantly associated with the standard measures of urinary symptoms in men with BPH, and that the magnitude of norepinephrine release during a postural tilt test predicts prostate size.²⁷ Put simply: the more revved-up your sympathetic nervous system is, the bigger the prostate tends to be and the worse the symptoms.

Animal experiments have made the case even more directly. Chronic stress in rats led to proliferative changes in the prostate, and when researchers chemically blocked the sympathetic nerve supply during the stress period, the hyperplasia didn’t develop.²⁸ This suggests that sympathetic overdrive has a direct growth-promoting effect on prostate tissue, independent of hormonal factors. It also helps explain why alpha-blocker medications, which counteract sympathetic tone in the prostate, are one of the first-line treatments for BPH symptoms.

Race and Ethnicity

The evidence on racial differences in BPH risk is surprisingly inconsistent, which itself is worth knowing. Data from the Prostate Cancer Prevention Trial found that Black and Hispanic men had 41 percent higher risk of BPH compared to white men, with even larger disparities for severe disease.²⁹ But the Health Professionals Follow-up Study found no increased risk for Black men and actually found that Asian men were less likely to undergo BPH surgery, while white men of southern European ancestry had modestly higher risk than those of Scandinavian heritage.³⁰

Adding another layer, a national survey found that Black men were roughly half as likely to report a BPH diagnosis compared with white men. But among those who did have BPH, Black men were more likely to have undergone surgery for it.³¹ That combination suggests a diagnostic gap: Black men may be getting diagnosed less frequently but presenting with more advanced disease when they are. Differences in healthcare access, screening patterns, and socioeconomic factors make it difficult to untangle genuine biological susceptibility from disparities in detection and treatment.

Sleep Apnea and Circadian Disruption

Obstructive sleep apnea has emerged as an underappreciated risk factor. The repeated drops in oxygen during sleep drive systemic inflammation, accelerate atherosclerosis, and worsen insulin resistance, all of which independently promote BPH. Sleep apnea also elevates hypoxia-inducible factor 1α, a protein that has been identified as a key player in prostate tissue proliferation.³² In short, sleep apnea hits multiple BPH pathways at once.

Shift work and circadian disruption add another dimension. A systematic review found that non-standard shift work was associated with worsened lower urinary tract symptoms, and that the association was strengthened in workers who also had shift work sleep disorder, a condition that affects up to one in five shift workers.³³ The disruption of circadian hormone rhythms and the chronic sleep deprivation that accompanies shift work may compound other metabolic and inflammatory risk factors.

Environmental Chemicals

Endocrine-disrupting chemicals, substances that interfere with normal hormone signaling, are an area of active research. Bisphenol A (BPA), found in some plastics and food-can linings, has been shown in rat studies to alter the expression of enzymes involved in testosterone-to-DHT conversion within prostate tissue.³⁴ Human data is still limited, but a case-control study in Hong Kong found that frequent BPA exposure through heating food in plastic containers or drinking hot water from plastic cups was associated with a three- to fourfold increase in BPH risk.³⁵ That’s a single study with the usual limitations of self-reported exposure data, but the magnitude of the association was large enough to attract attention. The broader concern is that lifelong, low-level exposure to chemicals that mimic or interfere with sex hormones could shift the androgen-estrogen balance in ways that favor prostate growth.

The Gut and Urinary Microbiome

The newest frontier in BPH research involves the communities of bacteria living in the gut and urinary tract. Changes in gut microbiota can alter the production of short-chain fatty acids and contribute to insulin resistance and other metabolic disturbances that may fuel prostate inflammation and accelerate symptom progression.³⁶ The gut microbiome also influences systemic inflammation and estrogen metabolism, both of which are relevant to BPH through the pathways described earlier in this article.

The urinary microbiome, once thought to be sterile, turns out to harbor its own bacterial communities, and these appear to differ in men with BPH. A systematic review of studies involving over 500 patients found a correlation between urinary microbiome imbalances and symptom severity, with specific bacterial types linked to higher symptom scores and PSA levels.³⁷ Whether the bacterial changes are driving the disease or merely reflecting it is not yet clear. But the microbiome is an area where diet and lifestyle intersect with biology in ways that could eventually open new approaches to managing or preventing prostate enlargement.